For 50 years, CRA has been a premier consulting firm. Each of our practice areas is highly regarded, and our consultants are recognized for their creative and multi-disciplinary approach to solving our clients’ complex problems in the US and throughout the world.

Early development obstacles of biosimilars and biobetters

Gregory K. Bell
Life Sciences

Dr.Gregory K. Bell is quoted in this article published by BioPharm International about the regulatory and legal issues associated with bringing recent biosimilars and biobetters to market. Click below to read the article.

BioPharm International